These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36638755)

  • 1. Current status of producing autologous hematopoietic stem cells.
    Li Z; Yang L
    Curr Res Transl Med; 2023; 71(1):103377. PubMed ID: 36638755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
    Hwang Y; Broxmeyer HE; Lee MR
    Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles.
    Panopoulos AD; Belmonte JC
    Curr Opin Hematol; 2012 Jul; 19(4):256-60. PubMed ID: 22555392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
    Phondeechareon T; Wattanapanitch M; U-Pratya Y; Damkham C; Klincumhom N; Lorthongpanich C; Kheolamai P; Laowtammathron C; Issaragrisil S
    Ann Hematol; 2016 Oct; 95(10):1617-25. PubMed ID: 27465155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects and challenges of induced pluripotent stem cells as a source of hematopoietic stem cells.
    van Bekkum DW; Mikkers HM
    Ann N Y Acad Sci; 2012 Aug; 1266():179-88. PubMed ID: 22901269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
    Suzuki N; Yamazaki S; Yamaguchi T; Okabe M; Masaki H; Takaki S; Otsu M; Nakauchi H
    Mol Ther; 2013 Jul; 21(7):1424-31. PubMed ID: 23670574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
    Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
    Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.
    Anurogo D; Yuli Prasetyo Budi N; Thi Ngo MH; Huang YH; Pawitan JA
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
    Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
    Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in Cell Fate Acquisition to Scid-Repopulating Activity from Hemogenic Endothelium of hiPSCs Derived from AML Patients Using Forced Transcription Factor Expression.
    Porras DP; Reid JC; Tanasijevic B; Golubeva D; Boyd AL; Bhatia M
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
    Oguro H
    Methods Mol Biol; 2019; 2048():245-257. PubMed ID: 31396942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling leukemia with pediatric acute leukemia patient-derived iPSCs.
    Li T; Zhang Y; Li Y; Wang X; Bao W; Huang J; Ma Y; Li S; Wang S; Yang Y; Liu Y; Gao Y; Feng H; Li Y
    Stem Cell Res; 2021 Jul; 54():102404. PubMed ID: 34111697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
    Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
    Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of transgene-free hematopoietic stem cells from human induced pluripotent stem cells.
    Piau O; Brunet-Manquat M; L'Homme B; Petit L; Birebent B; Linard C; Moeckes L; Zuliani T; Lapillonne H; Benderitter M; Douay L; Chapel A; Guyonneau-Harmand L; Jaffredo T
    Cell Stem Cell; 2023 Dec; 30(12):1610-1623.e7. PubMed ID: 38065068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro.
    Klump H; Teichweyde N; Meyer C; Horn PA
    Curr Mol Med; 2013 Jun; 13(5):815-20. PubMed ID: 23642062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.
    Kambal A; Mitchell G; Cary W; Gruenloh W; Jung Y; Kalomoiris S; Nacey C; McGee J; Lindsey M; Fury B; Bauer G; Nolta JA; Anderson JS
    Mol Ther; 2011 Mar; 19(3):584-93. PubMed ID: 21119622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of hematopoietic stem cells for use in autologous transplantation.
    Devine H; Tierney DK; Schmit-Pokorny K; McDermott K
    Clin J Oncol Nurs; 2010 Apr; 14(2):212-22. PubMed ID: 20350895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.